A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall

Detalles Bibliográficos
Autores principales: Kotanidis, CP, Lockstone, H, Polkinghorne, M, Badi, I, Akoumianakis, I, Siddique, M, Antonopoulos, A, Evans, T, Farid, S, Srivastava, V, Krasopoulos, G, Sayeed, R, Channon, KM, Antoniades, C
Formato: Conference item
Lenguaje:English
Publicado: Oxford University Press 2021

Ejemplares similares